| · Compliance aids (3)
· Pharmaceutical industry
· Euthanasia
· Overseas pharmacists
· The Council
Letters to the Editor
|
Pharmaceutical industry
Article’s comments unfair to industry
From Mr M. Harvey, MRPharmS
The tone and thrust of Harriet Adcock’s article, “Clinical
developments” (PJ, 7 January, pp23–6 PDF (110K)) is
myopic.
As is usual in pharmacy journals, the review fails to give credit to the
thriving industry of researchers and marketers in the pharmaceutical industry,
some of whom are pharmacists.
Without the efforts of the drug industry, pharmacy would be poorly served
indeed — do you not agree?
When will proper partnerships with industry be recognised and when will
the industry be given affirmations of its value instead of carping comments
like Dr Adcock’s? Phrases like “catapulting new products” and “trumpeting” advances
are unacceptably emotive and insulting to the careful work-up of all new
products before application for approval and licences.
The tone of the article is anti-industry and it need not be. There is no
attempt to evaluate the potential benefit of products developed to aid
the suffering of patients with illnesses that are being researched by professionals
in the pharmaceutical industry.
All the changes being brought about in front-line services would be scarcely
relevant without a thriving and productive pharmaceutical industry.
Mike Harvey
Chichester, West Sussex |
The
Pharmaceutical Journal